Jennifer E. Thomas

Assistant Professor, Department of Clinical and Administrative Sciences
Office: 2514
Phone: 305-760-7465
Hours: By Appointment

Education and Training

  • Pharm. D. – Nova Southeastern University, Fort Lauderdale, FL
  • A.A. – Tallahassee Community College, Tallahassee, FL
  • Neuro-Cognitive Fellowship, Nova Southeastern University, Davie, FL (focus on pharmacotherapy, psychiatry, HIV, geriatrics)
  • Board Certified Psychiatric Pharmacist
  • AAHIVP (HIV Pharmacist specialization)


Teaching Interests

My teaching interests include psychiatry, HIV, and women’s health.


Scholarly Interests

Dr. Thomas’s research interests include the areas of psychiatry, HIV, and substance use disorders.

Research Interests

My research interests include the areas of psychiatry, HIV, and substance use disorders.


Selected Publications

O’Halloran Leach E, Lu H, Caballero J, Thomas JE, Spencer EC, Cook RL. Defining the optimal cut-point of self-reported ART adherence to achieve viral suppression in the era of contemporary HIV therapy: a cross-sectional study. AIDS Res Ther. 2021; 18(1):36.

Allen Reeves A, Fuentes AV, Caballero J, Thomas JE, Mosley JF, Harrington C. Neurotoxicities in the treatment of HIV between dolutegravir, rilpivirine and dolutegravir/rilpivirine: a meta-analysis. Sex Transm Infect. 2021; 97(4):261-67.

Caballero J, Ownby RL, Jacobs RJ, Thomas JE, Schweizer MS. Association between cognitive tests and antiretroviral medication adherence in older adults with HIV. Ann Pharmacother. 2019;53(2):151-58.

Caballero J, Benavides S, Clauson KA, Hardigan PC, Steinberg JG, Gauthier TP, Sherman EM, Seamon MJ, Valdes J, Thomas JE. Role of residency interview preparatory activities as a determinant on pharmacy residency match rates. J Pharm Pract. 2017; 30(2):219-22.

Thomas JE, Jacobs RJ, Caballero J, Ownby RL, Lessmann EM, Mallare K, Adler M. Factors to assess depression in homebound older adults. Ment Health Clin. 2016; 6(5):236-41.

Thomas JE, Caballero J, Harrington CA. The incidence of akathisia in the treatment of schizophrenia with aripiprazole, asenapine and lurasidone: A meta-analysis. Curr Neuropharmacol. 2015; 13(5):681-91.